PETMED EXPRESS INC (PETS) Stock Fundamental Analysis
NASDAQ:PETS - US7163821066 - Common Stock
3.14 USD
+0.05 (+1.62%)
3.14 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to PETS. PETS was compared to 124 industry peers in the Specialty Retail industry. PETS has a great financial health rating, but its profitability evaluates not so good. PETS does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year PETS was profitable.
PETS had a positive operating cash flow in the past year.
PETS had positive earnings in 4 of the past 5 years.
PETS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of PETS (0.25%) is comparable to the rest of the industry.
PETS has a Return On Equity (0.37%) which is in line with its industry peers.
PETS has a Return On Invested Capital (1.24%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROIC | 1.24% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.14%, PETS is in line with its industry, outperforming 50.81% of the companies in the same industry.
With a Operating Margin value of 0.62%, PETS is not doing good in the industry: 60.48% of the companies in the same industry are doing better.
With a Gross Margin value of 27.68%, PETS is not doing good in the industry: 68.55% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PETS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
2. Health
2.1 Basic Checks
PETS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PETS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PETS has more shares outstanding
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PETS has an Altman-Z score of 3.47. This indicates that PETS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.47, PETS is doing good in the industry, outperforming 75.81% of the companies in the same industry.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.47 |
ROIC/WACC0.13
WACC9.37%
2.3 Liquidity
PETS has a Current Ratio of 1.43. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
PETS has a Current ratio (1.43) which is in line with its industry peers.
PETS has a Quick Ratio of 1.18. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PETS (1.18) is better than 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
PETS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.56%, which is quite impressive.
Looking at the last year, PETS shows a very negative growth in Revenue. The Revenue has decreased by -10.82% in the last year.
PETS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.17% yearly.
EPS 1Y (TTM)102.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)-10.82%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-18.88%
3.2 Future
PETS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.44% yearly.
The Revenue is expected to decrease by -7.30% on average over the next years.
EPS Next Y37.23%
EPS Next 2Y29.85%
EPS Next 3Y21.44%
EPS Next 5YN/A
Revenue Next Year-17.11%
Revenue Next 2Y-12.06%
Revenue Next 3Y-7.3%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 314.00 indicates a quite expensive valuation of PETS.
PETS's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of PETS to the average of the S&P500 Index (27.24), we can say PETS is valued expensively.
The Forward Price/Earnings Ratio is negative for PETS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 314 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PETS is valued cheaply inside the industry as 99.19% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as PETS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 75.87 | ||
| EV/EBITDA | 1.76 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PETS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as PETS's earnings are expected to grow with 21.44% in the coming years.
PEG (NY)8.43
PEG (5Y)N/A
EPS Next 2Y29.85%
EPS Next 3Y21.44%
5. Dividend
5.1 Amount
No dividends for PETS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.14
+0.05 (+1.62%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners40.93%
Inst Owner Change-7.72%
Ins Owners7.21%
Ins Owner Change7.53%
Market Cap64.87M
Analysts40
Price Target3.06 (-2.55%)
Short Float %12.86%
Short Ratio11.41
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.59
Dividend Growth(5Y)-11.13%
DP54.34%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-96.08%
Min EPS beat(2)-488.23%
Max EPS beat(2)296.08%
EPS beat(4)2
Avg EPS beat(4)-36.55%
Min EPS beat(4)-488.23%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)-169.93%
EPS beat(12)4
Avg EPS beat(12)-128.55%
EPS beat(16)4
Avg EPS beat(16)-101.84%
Revenue beat(2)0
Avg Revenue beat(2)-12.18%
Min Revenue beat(2)-12.84%
Max Revenue beat(2)-11.51%
Revenue beat(4)1
Avg Revenue beat(4)-8.81%
Min Revenue beat(4)-12.84%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-6.94%
Revenue beat(12)1
Avg Revenue beat(12)-6.81%
Revenue beat(16)1
Avg Revenue beat(16)-6.96%
PT rev (1m)-10.45%
PT rev (3m)-16.67%
EPS NQ rev (1m)-44.12%
EPS NQ rev (3m)-988.89%
EPS NY rev (1m)-200%
EPS NY rev (3m)-217.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.37%
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 314 | ||
| Fwd PE | N/A | ||
| P/S | 0.26 | ||
| P/FCF | 75.87 | ||
| P/OCF | 13.43 | ||
| P/B | 0.67 | ||
| P/tB | 1.19 | ||
| EV/EBITDA | 1.76 |
EPS(TTM)0.01
EY0.32%
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.04
FCFY1.32%
OCF(TTM)0.23
OCFY7.45%
SpS11.96
BVpS4.66
TBVpS2.64
PEG (NY)8.43
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROCE | 1.57% | ||
| ROIC | 1.24% | ||
| ROICexc | 2.57% | ||
| ROICexgc | 23.86% | ||
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% | ||
| FCFM | 0.35% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
F-Score7
Asset Turnover1.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 57.96% | ||
| Cap/Sales | 1.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.63% | ||
| Profit Quality | 239.5% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.47 |
F-Score7
WACC9.37%
ROIC/WACC0.13
Cap/Depr(3y)91.99%
Cap/Depr(5y)95.64%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y37.23%
EPS Next 2Y29.85%
EPS Next 3Y21.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.82%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-18.88%
Revenue Next Year-17.11%
Revenue Next 2Y-12.06%
Revenue Next 3Y-7.3%
Revenue Next 5YN/A
EBIT growth 1Y111.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year151.71%
EBIT Next 3Y42.82%
EBIT Next 5YN/A
FCF growth 1Y-96.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.97%
OCF growth 3Y-52.42%
OCF growth 5Y-37.46%